Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2
3(75.0%)
Phase 3
1(25.0%)
4Total
Phase 2(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05895838Phase 3Recruiting

The Danish Out-of-Hospital Cardiac Arrest Study

Role: lead

NCT06744361Phase 2Recruiting

Ketamine Sedation As Neuroprotective Agent Following Out-of-hospital Cardiac Arrest

Role: lead

NCT04624776Phase 2Completed

Steroid Treatment After Resuscitated Out-of-Hospital Cardiac Arrest

Role: lead

NCT05405504Unknown

Evaluation of ReDS Pro System V2.7 and ReDS ICU in Patients With Heart Failure

Role: lead

NCT03863015Phase 2Completed

IL-6 Inhibition for Modulating Inflammation After Cardiac Arrest

Role: lead

All 5 trials loaded